Company profile
SS Innovations International, Inc.
NASDAQ: SSII · Healthcare · Medical - Devices
#458 of 1,422 Healthcare companies by revenuetop-quartile growth
EA Score
53DFH 60DQ 29GM 73SS 66
v0.1 · 65/100 weight · provisional
↑ 3-yr revenue growth, Altman-Z · ↓ disclosure history, Piotroski F
Methodology →Revenue TTM
$48.4M
Rev growth YoY (TTM)
+148.2%
Net income (FY)
-$12.1M
Employees
483
as of 2026-08-11
Market cap
$750.5M
as of 2026-08-11
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$42.5M$42.5M2025
Net income-$12.1M-$12.1M2025
Operating income-$8.2M-$8.2M2025
Total assets$74.2M$74.2M2025
Liabilities$36.0M$36.0M2025
Equity$38.2M$38.2M2025
Revenue trend
FY2023 – FY2025 · USD
FY23
FY23
FY25
FY25
Revenue by segment
Filed disclosures · FY2025
By product
System Sales Member100%
By geography
INDIA87%
PHILIPPINES5%
INDONESIA2%
South America2%
IRAQ2%
CYPRUS1%
The read
What is SS Innovations International, Inc.’s revenue?
SS Innovations International, Inc. booked $42.5M in FY2025 revenue, growing 106% year over year — faster than most Healthcare companies we track, at a -28.5% net margin.
Peers · Healthcare
MedAvail Holdings, Inc.——Wave Life Sciences Ltd.63CRubicon Organics Inc.63CCoherus Oncology, Inc.61CBiofrontera Inc.46DSelectis Health, Inc.60CNeighbors
Broward →Key facts
CEOSudhir Prem Srivastava
SectorHealthcare
IndustryMedical - Devices
HeadquartersFort Lauderdale, FL
ExchangeNASDAQ: SSII
Employees483
IPO date2018-10-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.